2 not yet recruiting, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 2, Completed 1 |
Follow Gemcitabine alone: new trials by email Literature Review of Gemcitabine alone trials Research Report on Gemcitabine alone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer Cyclophosphamide+Pemetrexed+5-Fluorouracil, Cyclophosphamide+Doxorubicin+5-Fluorouracil, Vindesine + Cisplatin - Locally Advanced Thyroid Gland Carcinoma, Thyroid Cancer | Phase 2 | Not yet recruiting | West China Hospital | 20 | 2024-12-01 | 2024-12-03 |
| Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients Astragalus + Gemcitabine, Gemcitabine alone - Pancreatic Cancer | Phase 2 | Not yet recruiting | Shenzhen University General Hospital | 120 | 2024-02-01 | 2024-02-02 |
| EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Gemcitabine alone, EndoTAG-1 and Gemcitabine - Adenocarcinoma, Metastasis | Phase 2 | Completed | MediGene | 212 | 2005-09-01 | 2008-11-14 |
Pancreatic Neoplasms (2) · Adenocarcinoma (1) · Neoplasm Metastasis (1) · Thyroid Neoplasms (1)
MediGene (1) · Shenzhen University General Hospital (1) · West China Hospital (1)
China (2) · Czechia (1) · Hungary (1) · Ukraine (1)